CGNI — Cardiogeni Cashflow Statement
0.000.00%
Annual cashflow statement for Cardiogeni, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2024 March 31st | 2025 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | UAS | UAS |
| Status: | Final | Final |
| Changes in Working Capital | -0.447 | -3.03 |
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -0.369 | -3.03 |
| Capital Expenditures | -0.046 | -0.016 |
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | 0 | 0.002 |
| Sale/Maturity of Investment | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -0.046 | -0.013 |
| Financing Cash Flow Items | -0.177 | 0 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 0.446 | 2.79 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0.031 | -0.248 |